Home > Healthcare > Biotechnology > Biotechnology R&D > CRISPR and Cas Gene Market
CRISPR and Cas Gene Market Size
- Report ID: GMI6286
- Published Date: Jul 2023
- Report Format: PDF
CRISPR and Cas Gene Market Size
CRISPR and Cas Gene Market size accounted for USD 2.5 billion in 2022 and is estimated to grow at 21.7% to reach USD 17.4 billion by 2032. As the prevalence of genetic diseases and complex medical conditions continues to rise, there is an increasing demand for innovative treatments that can target the root cause of these ailments.
For instance, according to the Lancet Haematology report, in 2021, seaHaall-age prevalence of sickle cell disease among females and males was 3·9 million and 3·84 million respectively globally. By enabling precise and targeted modifications to DNA sequences, CRISPR allows researchers and pharmaceutical companies to develop customized gene therapy and precision medicine approaches.
| Report Attribute | Details |
|---|---|
| Base Year: | 2022 |
| CRISPR and Cas Gene Market Size in 2022: | USD 2.5 Billion |
| Forecast Period: | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR: | 21.7% |
| 2032 Value Projection: | USD 17.4 Billion |
| Historical Data for: | 2018 to 2022 |
| No. of Pages: | 220 |
| Tables, Charts & Figures: | 370 |
| Segments covered: | Product & Services, Application, End-use, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
CRISPR and Cas genes refer to gene-editing technologies used in molecular biology to modify DNA sequences with precision. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is a naturally occurring genetic mechanism found in bacteria and archaea that acts as an adaptive immune system against viral infections. Whereas, cas (CRISPR-associated) genes encode for cas proteins, which function as molecular scissors, capable of cleaving specific DNA sequences.
Frequently Asked Questions (FAQ) :
CRISPR and Cas Gene Market Scope
